A BETTER LIFE FOR SENSITIVE SKIN.
LA ROCHE-POSAY. Recommended by over 25,000 dermatologists. Sensitive skin specialist.

 

Rosaliac

 

Rosaliac
Home > Rosaliac > Rosaliac

Rosaliac

Skin Perfecting Anti-Redness Moisturizer

Neutralises outbreaks of redness. Restores comfort and brightness.

Skin type / Problematic

Vulnerable, reactive skin, fragile vessels.

Earnings

This soothing, moisturizing treatment with La Roche Posay thermal spring water transforms the skin and reveals a soft, supple texture, a bright, even complexion and lasting comfort.

How to use

Morning and/or evening. This fresh, enveloping emulsion, lightly green in tint to neutralise redness, is an excellent make-up base for the entire face.


more about  Rosaliac

Two complementary vitamins stop the appearance of redness to restore long-term comfort and brightness: > Vitamin B3 stimulates the skin's natural defences against irritants, to eliminate redness and reduce vessel reactions. > Vitamin CG fortifies vessel walls daily by activating collagen synthesis. Fragrance-free.

40ml pump dispenser

Efficacy
Effective against redness:
-34% on overall redness,
-44% on outbreaks of redness,
-26% on vessel visibility
Moisturizing Efficacy:
+34% after 8 hours
All products for Rosaliac
All products in the range Rosaliac
See Rosaliac AR Intense

Rosaliac AR Intense

Intensive care. Localized anti-redness. Fluid, ultra-fresh and non-oily gel. Non-comedogenic. Hypoallergenic.
All products in the range Rosaliac
See Rosaliac

Rosaliac

Skin Perfecting Anti-Redness Moisturizer
All products in the range Rosaliac
See Rosaliac UV Rich

Rosaliac UV Rich

Anti-redness moisturizer SPF 15 Protection Rich and nourishing cream.
All products in the range Rosaliac
See Rosaliac UV Light

Rosaliac UV Light

Anti-redness moisturizer SPF 15 Protection Soft and fresh emulsion, non-comedogenic.
product 1 /
Key Figure

65% Is the percentage of women over the age of 25 who say they suffer from redness on their face.


Source : Redness monitoring unit: study conducted in 2005 by the La Roche-Posay laboratory in 7 European countries and Canada on 2,500 people.

 

loading : 1,294 sec